Wipro partners with Transcell Oncologics to transform vaccine safety assessment

By applying augmented intelligence to the vaccine development process, the solution can predict adverse neurovirulent impacts resulting from vaccinations, says Wipro

from Tech-Economic Times https://ift.tt/3h2f6nI